Meeting
2021 Genitourinary Cancers Symposium
The BARCODE1 pilot study targeting men with increased genetic risk of developing prostate cancer: Examining the feasibility of a community-based screening program using polygenic risk score to target screening.
Authors
Jana Kathlyn McHugh
Institute of Cancer Research, London, United Kingdom
Jana Kathlyn McHugh , Sarah Benafif , Holly ni Raghallaigh , Elizabeth Bancroft , Zsofia Kote-Jarai , Ros A. Eeles
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Prostate Cancer - Localized Disease
Track
Prostate Cancer - Localized
Sub Track
Prevention, Screening, and Hereditary Cancers
Clinical Trial Registration Number
IRAS257684
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 227)
DOI
10.1200/JCO.2021.39.6_suppl.227
Abstract #
227
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
The BARCODE1 study in primary care: Early results targeting men with increased genetic risk of developing prostate cancer—Examining the interim data from a community-based screening program using polygenic risk score to target screening.
First Author: Jana Kathlyn McHugh
Poster
2023 ASCO Annual Meeting
Polygenic risk scores in assessing lung cancer susceptibility in non-Hispanic White and Black populations.
First Author: Matthew R Trendowski
Poster
2023 ASCO Genitourinary Cancers Symposium
The profile study: Prostate cancer screening in men of Black African and African Caribbean ancestry—Early results.
First Author: Netty Kinsella
Poster
2024 ASCO Annual Meeting
Association of a polygenic risk score with risk of abnormal ultrasound findings and ovarian cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
First Author: Sarah Phillips